PDB Short entry for 2GJD HEADER LIGASE 30-MAR-06 2GJD TITLE DISTINCT FUNCTIONAL DOMAINS OF UBC9 DICTATE CELL SURVIVAL AND TITLE 2 RESISTANCE TO GENOTOXIC STRESS COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN-CONJUGATING ENZYME E2-18 KDA; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: UBIQUITIN- PROTEIN LIGASE, UBIQUITIN CARRIER PROTEIN; COMPND 5 EC: 6.3.2.19; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 GENE: UBC9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS UBC9P, E2, SMT3, SACCHAROMYCES CEREVISIAE, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR R.C.VAN WAARDENBURG,D.M.DUDA,C.S.LANCASTER,B.A.SCHULMAN,M.A.BJORNSTI REVDAT 3 30-AUG-23 2GJD 1 REMARK REVDAT 2 24-FEB-09 2GJD 1 VERSN REVDAT 1 04-JUL-06 2GJD 0 JRNL AUTH R.C.VAN WAARDENBURG,D.M.DUDA,C.S.LANCASTER,B.A.SCHULMAN, JRNL AUTH 2 M.A.BJORNSTI JRNL TITL DISTINCT FUNCTIONAL DOMAINS OF UBC9 DICTATE CELL SURVIVAL JRNL TITL 2 AND RESISTANCE TO GENOTOXIC STRESS. JRNL REF MOL.CELL.BIOL. V. 26 4958 2006 JRNL REFN ISSN 0270-7306 JRNL PMID 16782883 JRNL DOI 10.1128/MCB.00160-06 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 65195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3311 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5014 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 473 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : ION.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GJD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000037190. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.100 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65226 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1U9A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 6000, 0.1M HEPES, 0.1M NABR, REMARK 280 5MM DTT, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.07050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY CONSISTS OF A CRYSTALLOGRAPHIC REMARK 300 TETRAMER MADE UP OF MOLECULES A,B,C, AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 MET B 1 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 MET D 1 REMARK 465 SER D 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 214 O HOH B 239 2.13 REMARK 500 OD2 ASP B 19 O HOH B 249 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ILE A 92 C CYS A 93 N 0.298 REMARK 500 ILE A 92 C CYS A 93 N 0.310 REMARK 500 CYS A 93 C LEU A 94 N 0.275 REMARK 500 CYS A 93 C LEU A 94 N 0.248 REMARK 500 CYS B 93 CB CYS B 93 SG -0.115 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 101 -101.81 -119.16 REMARK 500 SER A 127 50.97 -152.39 REMARK 500 SER B 3 -29.90 -12.53 REMARK 500 HIS B 83 141.04 -172.85 REMARK 500 GLN B 101 -104.98 -128.27 REMARK 500 GLN C 101 -99.29 -128.51 REMARK 500 ASN C 140 70.85 -150.58 REMARK 500 SER C 156 -157.95 -80.97 REMARK 500 HIS D 83 141.02 -171.93 REMARK 500 GLN D 101 -102.67 -128.97 REMARK 500 ASN D 140 69.98 -150.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER B 2 SER B 3 -140.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A3S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN UBC9 REMARK 900 RELATED ID: 1U9A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBC9 DBREF 2GJD A 1 157 UNP P50623 UBC9_YEAST 1 157 DBREF 2GJD B 1 157 UNP P50623 UBC9_YEAST 1 157 DBREF 2GJD C 1 157 UNP P50623 UBC9_YEAST 1 157 DBREF 2GJD D 1 157 UNP P50623 UBC9_YEAST 1 157 SEQRES 1 A 157 MET SER SER LEU CYS LEU GLN ARG LEU GLN GLU GLU ARG SEQRES 2 A 157 LYS LYS TRP ARG LYS ASP HIS PRO PHE GLY PHE TYR ALA SEQRES 3 A 157 LYS PRO VAL LYS LYS ALA ASP GLY SER MET ASP LEU GLN SEQRES 4 A 157 LYS TRP GLU ALA GLY ILE PRO GLY LYS GLU GLY THR ASN SEQRES 5 A 157 TRP ALA GLY GLY VAL TYR PRO ILE THR VAL GLU TYR PRO SEQRES 6 A 157 ASN GLU TYR PRO SER LYS PRO PRO LYS VAL LYS PHE PRO SEQRES 7 A 157 ALA GLY PHE TYR HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 A 157 ILE CYS LEU SER ILE LEU ASN GLU ASP GLN ASP TRP ARG SEQRES 9 A 157 PRO ALA ILE THR LEU LYS GLN ILE VAL LEU GLY VAL GLN SEQRES 10 A 157 ASP LEU LEU ASP SER PRO ASN PRO ASN SER PRO ALA GLN SEQRES 11 A 157 GLU PRO ALA TRP ARG SER PHE SER ARG ASN LYS ALA GLU SEQRES 12 A 157 TYR ASP LYS LYS VAL LEU LEU GLN ALA LYS GLN TYR SER SEQRES 13 A 157 LYS SEQRES 1 B 157 MET SER SER LEU CYS LEU GLN ARG LEU GLN GLU GLU ARG SEQRES 2 B 157 LYS LYS TRP ARG LYS ASP HIS PRO PHE GLY PHE TYR ALA SEQRES 3 B 157 LYS PRO VAL LYS LYS ALA ASP GLY SER MET ASP LEU GLN SEQRES 4 B 157 LYS TRP GLU ALA GLY ILE PRO GLY LYS GLU GLY THR ASN SEQRES 5 B 157 TRP ALA GLY GLY VAL TYR PRO ILE THR VAL GLU TYR PRO SEQRES 6 B 157 ASN GLU TYR PRO SER LYS PRO PRO LYS VAL LYS PHE PRO SEQRES 7 B 157 ALA GLY PHE TYR HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 B 157 ILE CYS LEU SER ILE LEU ASN GLU ASP GLN ASP TRP ARG SEQRES 9 B 157 PRO ALA ILE THR LEU LYS GLN ILE VAL LEU GLY VAL GLN SEQRES 10 B 157 ASP LEU LEU ASP SER PRO ASN PRO ASN SER PRO ALA GLN SEQRES 11 B 157 GLU PRO ALA TRP ARG SER PHE SER ARG ASN LYS ALA GLU SEQRES 12 B 157 TYR ASP LYS LYS VAL LEU LEU GLN ALA LYS GLN TYR SER SEQRES 13 B 157 LYS SEQRES 1 C 157 MET SER SER LEU CYS LEU GLN ARG LEU GLN GLU GLU ARG SEQRES 2 C 157 LYS LYS TRP ARG LYS ASP HIS PRO PHE GLY PHE TYR ALA SEQRES 3 C 157 LYS PRO VAL LYS LYS ALA ASP GLY SER MET ASP LEU GLN SEQRES 4 C 157 LYS TRP GLU ALA GLY ILE PRO GLY LYS GLU GLY THR ASN SEQRES 5 C 157 TRP ALA GLY GLY VAL TYR PRO ILE THR VAL GLU TYR PRO SEQRES 6 C 157 ASN GLU TYR PRO SER LYS PRO PRO LYS VAL LYS PHE PRO SEQRES 7 C 157 ALA GLY PHE TYR HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 C 157 ILE CYS LEU SER ILE LEU ASN GLU ASP GLN ASP TRP ARG SEQRES 9 C 157 PRO ALA ILE THR LEU LYS GLN ILE VAL LEU GLY VAL GLN SEQRES 10 C 157 ASP LEU LEU ASP SER PRO ASN PRO ASN SER PRO ALA GLN SEQRES 11 C 157 GLU PRO ALA TRP ARG SER PHE SER ARG ASN LYS ALA GLU SEQRES 12 C 157 TYR ASP LYS LYS VAL LEU LEU GLN ALA LYS GLN TYR SER SEQRES 13 C 157 LYS SEQRES 1 D 157 MET SER SER LEU CYS LEU GLN ARG LEU GLN GLU GLU ARG SEQRES 2 D 157 LYS LYS TRP ARG LYS ASP HIS PRO PHE GLY PHE TYR ALA SEQRES 3 D 157 LYS PRO VAL LYS LYS ALA ASP GLY SER MET ASP LEU GLN SEQRES 4 D 157 LYS TRP GLU ALA GLY ILE PRO GLY LYS GLU GLY THR ASN SEQRES 5 D 157 TRP ALA GLY GLY VAL TYR PRO ILE THR VAL GLU TYR PRO SEQRES 6 D 157 ASN GLU TYR PRO SER LYS PRO PRO LYS VAL LYS PHE PRO SEQRES 7 D 157 ALA GLY PHE TYR HIS PRO ASN VAL TYR PRO SER GLY THR SEQRES 8 D 157 ILE CYS LEU SER ILE LEU ASN GLU ASP GLN ASP TRP ARG SEQRES 9 D 157 PRO ALA ILE THR LEU LYS GLN ILE VAL LEU GLY VAL GLN SEQRES 10 D 157 ASP LEU LEU ASP SER PRO ASN PRO ASN SER PRO ALA GLN SEQRES 11 D 157 GLU PRO ALA TRP ARG SER PHE SER ARG ASN LYS ALA GLU SEQRES 12 D 157 TYR ASP LYS LYS VAL LEU LEU GLN ALA LYS GLN TYR SER SEQRES 13 D 157 LYS FORMUL 5 HOH *473(H2 O) HELIX 1 1 SER A 3 ASP A 19 1 17 HELIX 2 2 LEU A 94 ASN A 98 5 5 HELIX 3 3 THR A 108 ASP A 121 1 14 HELIX 4 4 GLN A 130 ASN A 140 1 11 HELIX 5 5 ASN A 140 TYR A 155 1 16 HELIX 6 6 SER B 3 ASP B 19 1 17 HELIX 7 7 LEU B 94 ASN B 98 5 5 HELIX 8 8 THR B 108 SER B 122 1 15 HELIX 9 9 GLN B 130 ASN B 140 1 11 HELIX 10 10 ASN B 140 TYR B 155 1 16 HELIX 11 11 SER C 3 HIS C 20 1 18 HELIX 12 12 LEU C 94 ASN C 98 5 5 HELIX 13 13 THR C 108 LEU C 120 1 13 HELIX 14 14 GLN C 130 ASN C 140 1 11 HELIX 15 15 ASN C 140 TYR C 155 1 16 HELIX 16 16 SER D 3 ASP D 19 1 17 HELIX 17 17 LEU D 94 ASN D 98 5 5 HELIX 18 18 THR D 108 ASP D 121 1 14 HELIX 19 19 GLN D 130 ASN D 140 1 11 HELIX 20 20 ASN D 140 TYR D 155 1 16 SHEET 1 A 4 TYR A 25 LYS A 30 0 SHEET 2 A 4 MET A 36 PRO A 46 -1 O ASP A 37 N VAL A 29 SHEET 3 A 4 VAL A 57 GLU A 63 -1 O TYR A 58 N ILE A 45 SHEET 4 A 4 LYS A 74 LYS A 76 -1 O LYS A 74 N GLU A 63 SHEET 1 B 4 TYR B 25 LYS B 30 0 SHEET 2 B 4 MET B 36 PRO B 46 -1 O GLU B 42 N LYS B 27 SHEET 3 B 4 VAL B 57 GLU B 63 -1 O ILE B 60 N ALA B 43 SHEET 4 B 4 LYS B 74 LYS B 76 -1 O LYS B 74 N GLU B 63 SHEET 1 C 4 TYR C 25 LYS C 30 0 SHEET 2 C 4 MET C 36 PRO C 46 -1 O GLU C 42 N LYS C 27 SHEET 3 C 4 VAL C 57 GLU C 63 -1 O TYR C 58 N ILE C 45 SHEET 4 C 4 LYS C 74 LYS C 76 -1 O LYS C 74 N GLU C 63 SHEET 1 D 4 TYR D 25 LYS D 30 0 SHEET 2 D 4 MET D 36 PRO D 46 -1 O ASP D 37 N VAL D 29 SHEET 3 D 4 VAL D 57 GLU D 63 -1 O TYR D 58 N ILE D 45 SHEET 4 D 4 LYS D 74 LYS D 76 -1 O LYS D 74 N GLU D 63 CISPEP 1 TYR A 68 PRO A 69 0 3.27 CISPEP 2 TYR B 68 PRO B 69 0 2.85 CISPEP 3 TYR C 68 PRO C 69 0 0.48 CISPEP 4 TYR D 68 PRO D 69 0 -0.29 CRYST1 59.304 60.141 95.287 90.00 105.01 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016862 0.000000 0.004521 0.00000 SCALE2 0.000000 0.016628 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010865 0.00000